SK Life Science - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsSK Life Science

SK Life Science

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Xcopri	Cenobamate	2020-03-10	2032-2039	Epilepsy , Partial epilepsies

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

healthy volunteers/patients

,

nervous system diseases

,

,

,

hepatic insufficiency

,

partial epilepsies

,

generalized epilepsy

,

,

,

partial epilepsy motor

,

,

allergic rhinitis

,

,

allergic conjunctivitis

,

liver neoplasms

,

atopic dermatitis

,

,

healthy volunteers/patients

,

,

,

,

,

prostatic neoplasms

,

postoperative nausea and vomiting

,

,

brain neoplasms

,

second primary neoplasms

,

,

treatment-resistant depressive disorder

,

depressive disorder

,

esophageal neoplasms

,

esophageal squamous cell carcinoma

,

hematologic neoplasms

,

,

pseudomonas infections

,

pseudomonas aeruginosa

,

,

renal cell carcinoma

,

liver cirrhosis

,

experimental liver cirrhosis

,

chronic obstructive pulmonary disease

,

nasopharyngeal carcinoma

,

nasopharyngeal neoplasms

,

,

colorectal neoplasms

,

pancreatic ductal carcinoma

,

gastrointestinal neoplasms

,

biliary tract neoplasms

,

non-small-cell lung carcinoma

,

,

,

acquired immunodeficiency syndrome

,

,

ovarian neoplasms

,

breast neoplasms

,

uterine cervical neoplasms

,

condylomata acuminata

,

,

hepatocellular carcinoma

,

ovarian epithelial carcinoma

,

triple negative breast neoplasms

,

,

immunologic deficiency syndromes

,

,

antibiotic prophylaxis

,

,

chronic hepatitis b

,

coronary disease

,

coronary artery disease

,

myocardial ischemia

,

,

,

cystic fibrosis

,

pulmonary hypertension

,

pulmonary arterial hypertension

,

endometrial neoplasms

,

,

,

chronic hepatitis c

,

,

,

,

,

,

neuromuscular blockade

,

chronic kidney failure

,

kidney diseases

,

chronic hepatitis

,

intestinal diseases

,

non-hodgkin lymphoma

,

,

,

traumatic brain injuries

,

brain concussion

,

,

post-concussion syndrome

,

papillomavirus infections

,

uterine cervical dysplasia

,

irritable bowel syndrome

,

healthy volunteers/patients

therapeutic equivalency

,

pharmacokinetics

,

,

communicable diseases

,

,

alzheimer disease

,

,

juvenile arthritis

,

,

,

chronic pancreatitis

,

exercise-induced asthma

,

breast neoplasms

,

hematologic neoplasms

,

,

,

,

gastrointestinal diseases

,

,

,

,

peptic ulcer hemorrhage

,

rheumatoid arthritis

,

,

,

gastrointestinal hemorrhage

,

digestive system diseases

,

digestive signs and symptoms

,

simian acquired immunodeficiency syndrome

,

eosinophilic esophagitis

,

esophageal neoplasms

,

precancerous conditions

,

,

,

,

zollinger-ellison syndrome

,

,

postpartum hemorrhage

,

gastroesophageal reflux

,

peptic esophagitis

,

,

healthy volunteers/patients

,

,

,

,

barrett esophagus

,

non-erosive reflux disease

,

laryngopharyngeal reflux

,

,

,

,

,

atrophic gastritis

,

,

,

,

bariatric surgery

,

critical illness

,

,

,

pathologic constriction

,

,

,

microscopic colitis

,

,

metabolic diseases

,

calcium metabolism disorders

,

,

,

vasomotor rhinitis

healthy volunteers/patients

,

b-cell chronic lymphocytic leukemia

,

lymphoid leukemia

,

depressive disorder

,

treatment-resistant depressive disorder

,

peripheral nervous system diseases

,

diabetic neuropathies

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use